Adam D. Gridley

BioForm Medical, Inc. is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient's appearance. Their core product is Radiesse dermal filler, an injectable dermal filler designed to provide aesthetic improvement for patients. The company also offers Radiesse Voice and Radiesse Voice Gel for vocal fold insufficiency and Coaptite as a treatment for women who have stress urinary incontinence. BioForm Medical was founded in 1999 and is headquartered in San Mateo, CA.

Gliatech, Inc. engages in the discovery and development of bio surgery and pharmaceutical products. The company was founded on August 12, 1987 and is headquartered in Cleveland, OH.

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Merz North America, Inc. operates as an specialty healthcare company. It offers treatment solutions for aesthetics, dermatology and neurosciences. The company was founded in 1908 and is headquartered in Raleigh, NC.

Merz Aesthetics, Inc. is a medical aesthetics business that offers injectables, devices, and skin care treatments to empower healthcare professionals, patients, and employees to live confidently. The company is based in San Mateo, CA, USA, with locations in 32 countries worldwide. The company has a long history of building unique connections with customers who feel like family. Merz Aesthetics is part of the Merz Group, a family-owned company founded in 1908.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD.

Foundry Therapeutics 1, Inc. engages in the development of pharmaceutical products. The company is headquartered in Menlo Park, CA.